Automated and Rapid Microbiological Tests - A Worldwide Market Review

1.METHODOLOGY
Study Reliability and Reporting Limitations
Disclaimers
Quantitative Techniques & Reporting Level
2.GLOBAL MARKET OVERVIEW AND OUTLOOK
Outlook
Evolutionary Battle Against Bugs Drives Future of the Market
Automated Microbiological Tests: A Pesky Gray Area in the Clinical Diagnostics Market
Traditional Rapid Microbiological Tests Destined to Go Out With the Old
A Current & Future Analysis
Macro: The Big Picture
Deciding the Market’s Future
A Holistic Peek into a Few Noteworthy Trends
Biotechnology & Rapid Microbial Tests
Automated & Rapid Microbiological Tests: "Current Market Stance"
A Business Case for Automated & Rapid Microbiological Testing
Near Patient Testing: An Offshoot of Rapid Microbiological Tests
Pros & Cons of Near Patient Testing
Role of Near Patient Testing in Reducing Antibiotic Resistance in Humans
The Pre/Post Microbial Rapid Testing Era: A Review
Market Structure
Competitive Setup of the Diverse Automated & Rapid Microbiology Products Market
Historic Data
3.TRENDS & ISSUES
Advancements in Molecular Diagnostics - A Boon or a Threat
Antibiotic Resistant Bacteria Throws the Spotlight On Microbial Testing
Instant Detection of Pathogens – A New Epoch in the Fight for Survival
Lower Cost Rapid Tests Built on Multiple Sampling Modalities – Gaining Momentum
"Time Constraints?" - Rapid Tests to the Rescue
Rapid HIV Tests: A New Age Diagnostic Weapon Against the Killer Disease
Accuracy/Reliability of Home HIV Testing: A Bone of Contention
Development of Near Patient Test Kits: A Market Driven Phenomenon
Near Patient Test Kits: A Rumination of Possibilities
Automated Blood Culture Systems: A Winning Edge in the Fight Against Bacteremia
Leading Food Processors Resort to Rapid Microbiological Testing
Impact of Food Scares on Rapid Microbiological Tests Market
Demand for Microbiological Tests & Level of QC in the Food Industry
Rapid Tests Creating Brighter Avenues in Food Microbiology Testing Market
Dire Need to Nip Operating Costs Throws the Spotlight on Rapid Tests
Key Advantages/Benefits of Rapid Microbiological Tests on Food
Food Packages of the Future Ingrained with Microbial Alert Systems
Technology Innovations in Rapid Food Microbial Testing
Obtaining Regulatory Approval – A Major Non-Technical Hindrance
4.FACTORS INFLUENCING THE MARKET
Continuing Biological Warfare with Pathogens Sparks Market Growth
Innovative Products – A Key Growth Strategy
Other Market Drivers in a Capsule
Low Turnaround Times Skyrocket Demand
Greater Patient Awareness
Rising Incidence of STDs Kindles Universal Market Acceptance
Ultra-Rapid HIV-Screening Tests- A Strong Fight against HIV-Epidemic
Validation of Rapid Microbiological Tests: An Imperative Prerequisite
Non-Conformance to Testing Requirements: A Weighty Concern
Influenza – Boosting Rapid Test Prospects
5.PRODUCT FACTS
1. Clinical Applications
Automated Identification and Susceptibility Systems
Automated Blood Culture Systems
Automated Tuberculosis Systems
Streptococcal Infection Rapid Tests
GC/Chlamydia Rapid Tests
Other Automated & Rapid Microbiological Tests
2. Non-Clinical Applications
6.CORPORATE DEVELOPMENTS
BD Establishes New Rapid Diagnostic Products Manufacturing Facility in China
Quidel Corporation Obtains CLIA Waiver from FDA for its QuickVue(R) RSV Test
Siemens Obtains US FDA Approval for its VERSANT™ 440 Molecular System (USA)
bioMérieux to Market Wescor’s Customized Slide Stainer Instruments under bioMérieux Brand
Schering-Plough and OraSure Ink Collaboration Agreement for Developing Rapid Oral HCV Test
Abbott Obtains US FDA Approval for its Automated HTLV-I/HTLV-II Blood Screening Test (USA)
Quidel and bioMérieux Form a Long-term Alliance in Rapid Diagnostic Tests
BD Diagnostics Obtains US FDA Approval for BD GeneOhm™ StaphSR Assay
Meridian Bioscience Rolls Out Two New Rapid Tests for Detecting Epstein- Barr Virus
Oxoid Introduces Staph Plus System for Identifying Staphylococcal Species
Meridian Bioscience Obtains US FDA Approval for Two New Rapid Tests
Siemens AG Acquires Dade Behring
Thermo Fisher Scientific Teams Up with KBA for Expanding its Microbiology Business Division in Lenexa
OraSure and SCMS Enter into an Agreement for Supplying OraQuick(R) HIV Test to PEPFAR Countries
Abbott Obtains US FDA Approval for its Fully Automated PRISM® HCV Test
Gen-Probe Obtains US FDA Approval for its PROCLEIX® TIGRIS® System for Testing Donated Blood
AdvanDx Ropes in bioMérieux for Distributing its Rapid Diagnostic Tests in US
3M and Gen-Probe Join Hands to Develop Rapid Molecular Tests For Detecting HAIs (USA)
Gen-Probe’s PROCLEIX® TIGRIS® System Obtains US FDA Approval for Screening Donated Blood for West Nile Virus
3M Acquires Acolyte Biomedica
Formation of Siemens Medical Solutions Diagnostics
bioMérieux Bags Contract to Provide VITEK® 2 System for Scottish NHS Labs
bioMérieux Licenses NorChip’s HPV Test Technology for Cervical Cancer
bioMérieux in Strategic Agreement with Cepheid for Sepsis Assays
3M Health Care Creates New Medical Diagnostics Unit
Schering-Plough & OraSure to Develop Rapid Oral HCV Test
Siemens Healthcare Diagnostics Launches MicroScan® WalkAway® plus Diagnostic Microbiology Systems
Bio-Rad Launches a Rapid test for Screening MRSA, MRSASelect™ test, in US
bioMérieux Introduces VIDAS®, an automated Clostridium difficile A & B Toxins Detection Test
Oxoid Launches Remel Wellcolex® Colour Tests for Testing Shigella, E. coli O157 and Salmonella
Siemens Healthcare Diagnostics Obtains Health Canada Approval for its VERSANT 440 Molecular System
Oxoid Unveils Remel Xpect™ Clostridium Difficile Toxin A/B Test
Neogen Introduces Soleris System
ATCC Introduces Authenticult™ Quality Control Microbiological Testing Tool
Bio-Rad Introduces New EBV Kits
Roche Seeks FDA Marketing Approval for Hepatitis C Virus Test
Roche Seeks US FDA Approval for its Cobas TaqScreen MPX Test
FDA Clears Usage of TIGRIS® System for Testing WNV in Donated Blood
FDA Approves ImmunoCard STAT!® EHEC for Detecting E. coli Infection
7.MAJOR PLAYERS
Abbott Laboratories (USA)
Abbott Diagnostics (USA)
Becton Dickinson and Company (USA)
bioMerieux (France)
bioMerieux, Inc. (USA)
Bio-Rad Laboratories (USA)
Cellabs Pty Ltd (Australia)
Celsis International Plc (UK)
Coris BioConcept (Belgium)
F. Hoffmann-La Roche Ltd. (Switzerland)
Gen-Probe Incorporated (USA)
Genzyme Diagnostics (USA)
Inverness Medical Innovations, Inc. (USA)
MedMira, Inc. (Canada)
Meridian Biosciences, Inc. (USA)
Orasure Technologies, Inc. (USA)
Orion Diagnostica Oy (Finland)
Quidel Corporation (USA)
Siemens Healthcare Diagnostics (USA)
Thermo Fisher Scientific, Inc. (USA)
Remel, Inc. (USA)
Oxoid Limited (UK)
8.GLOBAL MARKET ANALYTICS
9.THE UNITED STATES
Rapid Microbiology Tests - A Competitive Profile
Consolidation in the Automated and Rapid Microbiological Tests Market
Bioterrorism Tests – Gaining Prominence
Tracking Trends Across Product Segments
STD Rapid Tests
Market Share Trends of Leading Players:
Leading Players in HIV Rapid Testing Market
Gastrointestinal Rapid Tests
Market Share Trends of Leading Players
Respiratory Rapid Tests
Competition
Streptococcus Infection Rapid Tests
Average Prices
A Peek into the Testing Practices of the US Food Industry
10.EUROPE
a.France
b.Germany
c.The United Kingdom
d.Italy
e.Spain
f.Russia
g.Rest of Europe
11.REST OF WORLD
Latin American Market
Asia-Pacific – The Next Epicenter for the AIDS Epidemic
Table 1: Percentage Breakdown of Leading Players in World Market for IVD Automated Microbiology Systems –
Table 2: Global Automated and Rapid Microbiological Tests Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 3: Percentage Breakdown of Global Automated and Rapid Microbiological Tests Market by Region for the Years 2008 & 2009 2009
Table 4: Global Market for Automated and Rapid Microbiological Tests in Clinical Applications by Region for the Period 2007-2015 (Sales in US$ Million)
Table 5: Percentage Breakdown of Global Market for Automated and Rapid Microbiological Tests in Clinical Applications by Region for the Years 2008 & 2009 2009
Table 6: Global Market for Automated and Rapid Microbiological Tests in Clinical Applications by Equipment Used for the Period 2007-2015 (Sales in US$ Million)
Table 7: Percentage Breakdown of Global Market for Automated and Rapid Microbiological Tests in Clinical Applications by Equipment Used for the Years 2008 & 2009 2009
Table 8: Global Market for Automated Identification & Susceptibility Systems in Clinical Applications by Region for the Period 2007-2015 (Sales in US$ Million)
Table 9: Percentage Breakdown of Global Market for Automated Identification & Susceptibility Systems in Clinical Applications by Region for the Years 2008 & 2009 2009
Table 10: Global Market for Automated Blood Culture Systems in Clinical Applications by Region for the Period 2007-2015 (Sales in US$ Million)
Table 11: Percentage Breakdown of Global Market for Automated Blood Culture Systems in Clinical Applications by Region for the Years 2008 & 2009 2009
Table 12: Global Market for Automated Tuberculosis Systems in Clinical Applications by Region for the Period 2007-2015 (Sales in US$ Million)
Table 13: Percentage Breakdown of Global Market for Automated Tuberculosis Systems in Clinical Applications by Region for the Years 2008 & 2009 2009
Table 14: Global Market for Streptococcal Infection Rapid Tests in Clinical Applications by Region for the Period 2007-2015 (Sales in US$ Million)
Table 15: Percentage Breakdown of Global Market for Streptococcal Infection Rapid Tests in Clinical Applications by Region for the Years 2008 & 2009 2009
Table 16: Global Market for GC/Chlamydia Rapid Tests in Clinical Applications by Region for the Period 2007-2015 (Sales in US$ Million)
Table 17: Percentage Breakdown of Global Market for GC/Chlamydia Rapid Tests in Clinical Applications by Region for the Years 2008 & 2009 2009
Table 18: Global Market for Other Automated & Rapid Microbiological Tests in Clinical Applications by Region for the Period 2007-2015 (Sales in US$ Million)
Table 19: Percentage Breakdown of Global Market for Other Automated & Rapid Microbiological Tests in Clinical Applications by Region for the Years 2008 & 2009 2009
Table 20: Global Market for Automated and Rapid Microbiological Tests in Non-Clinical Applications by Region for the Period 2007-2015 (Sales in US$ Million)
Table 21: Percentage Breakdown of Global Market for Automated and Rapid Microbiological Tests in Non-Clinical Applications by Region for the Years 2008 & 2009 2009
Table 22: Percentage Breakdown of Leading Players in the US Market for GC/Chlamydia Rapid Tests –
Table 23: Percentage Breakdown of Leading Players in the US Market for Chlamydia Rapid Tests –
Table 24: Percentage Breakdown of Leading Players in the US Market for Syphilis Rapid Tests –
Table 25: Percentage Breakdown of Leading Players in the US Market for C. Difficile Rapid Tests –
Table 26: Percentage Breakdown of Leading Players in the US Market for Cryptosporidium Rapid Tests -
Table 27: Percentage Breakdown of Leading Players in the US Market for Rotavirus Rapid Tests –
Table 28: Percentage Breakdown of Leading Players in the US Market for Giardia Rapid Tests -
Table 29: Percentage Breakdown of Leading Players in the US Market for Influenza Rapid Tests –
Table 30: Percentage Breakdown of Leading Players in the US Market for RSV Rapid Tests -
Table 31: Percentage Breakdown of Leading Players in the US Marketfor Tuberculosis Rapid Tests –
Table 32: Percentage Breakdown of Leading Players in the US Market for M. Pneumoniae Rapid Tests -
Table 33: Percentage Breakdown of Leading Players in the US Market for Mononucleosis Rapid Tests -
Table 34: Percentage Breakdown of Leading Players in the USMarket for Streptococcus A Rapid Tests -
Table 35: Average Costs for Rapid Tests in the US
Table 36: Automated and Rapid Microbiological Tests Market by End-Use Segment in the US: 2007-2015 (Sales in US$ Million)
Table 37: Percentage Breakdown of Automated and Rapid Microbiological Tests Market by End-Use Segment in the US for the Years 2008 & 2009 2009
Table 38: Rapid Microbiological Tests Market by End-Use Segment in the US: 2007-2015 (Sales in US$ Million)
Table 39: Percentage Breakdown of Rapid Microbiological Tests Market by End-Use Segment in the US for the Years 2008 & 2009 2009
Table 40: Percentage Breakdown of Leading Players in European Market for Automated & Rapid Microbiological Tests –
Table 41: Percentage Breakdown of Leading Players in European Market for Chlamydia Rapid Tests –
Table 42: Percentage Breakdown of Leading Players in European Market for Streptococcal Infection (Strep A) Rapid Tests -
Table 43: Percentage Breakdown of Leading Players in European Market for Automated Blood Culture Systems –
Table 44: Automated and Rapid Microbiological Tests Market by Region in Europe: 2007-2015 (Sales in US$ Million)
Table 45: Percentage Breakdown of Automated and Rapid Microbiological Tests Market by Region in Europe for the Years 2008 & 2009 2009
Table 46: Automated and Rapid Microbiological Tests Market by End-Use Segment in Europe: 2007-2015 (Sales in US$ Million)
Table 47: Percentage Breakdown of Automated and Rapid Microbiological Tests Market by End-Use Segment in Europe for the Years 2008 & 2009 2009
Table 48: Percentage Breakdown of Leading Players in French Market for Automated & Rapid Microbiological Tests –
Table 49: Percentage Breakdown of Leading Players in French Market for Chlamydia Rapid Tests –
Table 50: Percentage Breakdown of Leading Players in French Market for Automated Tuberculosis Systems -
Table 51: Percentage Breakdown of Leading Players in French Market for Automated Blood Culture Systems –
Table 52: Percentage Breakdown of Leading Players in French Market for Automated Identification and Susceptibility Systems –
Table 53: Automated and Rapid Microbiological Tests Market by End- Use Segment in France: 2007-2015 (Sales in US$ Million)
Table 54: Percentage Breakdown of Automated and Rapid Microbiological Tests Market by End-Use Segment in France for the Years 2008 & 2009 2009
Table 55: Percentage Breakdown of Leading Players in German Market for Automated & Rapid Microbiological Tests –
Table 56: Percentage Breakdown of Leading Players in German Market for Streptococcal Infection Rapid Tests –
Table 57: Percentage Breakdown of Leading Players in German Market for Automated Tuberculosis Systems -
Table 58: Percentage Breakdown of Leading Players in German Market for Automated Blood Culture Systems –
Table 59: Percentage Breakdown of Leading Players in German Market for Chlamydia Rapid Tests –
Table 60: Percentage Breakdown of Leading Players in German Market for Automated Identification and Susceptibility Systems –
Table 61: Automated and Rapid Microbiological Tests Market by End-Use Segment in Germany: 2007-2015 (Sales in US$ Million)
Table 62: Percentage Breakdown of Automated and Rapid Microbiological Tests Market by End-Use Segment in Germany for the Years 2008 & 2009 2009
Table 63: Percentage Breakdown of Leading Players in the UK Market for Automated & Rapid Microbiological Tests –
Table 64: Percentage Breakdown of Leading Players in the UK Market for Chlamydia Rapid Tests -
Table 65: Percentage Breakdown of Leading Players in the UK Market for Automated Tuberculosis Systems –
Table 66: Percentage Breakdown of Leading Players in the UK Market for Automated Identification and Susceptibility Systems –
Table 67: Percentage Breakdown of Leading Players in the UK Market for Streptococcal Infection Rapid Tests -
Table 68: Percentage Breakdown of Leading Players in the UK Market for Automated Blood Culture Systems -
Table 69: Automated and Rapid Microbiological Tests Market by End-Use Segment in the UK: 2007-2015 (Sales in US$ Million)
Table 70: Percentage Breakdown of Automated and Rapid Microbiological Tests Market by End-Use Segment in the UK for the Years 2008 & 2009 2009
Table 71: Percentage Breakdown of Leading Players in Italian Market for Automated & Rapid Microbiological Tests –
Table 72: Percentage Breakdown of Leading Players in Italian Market for Streptococcal Infection Rapid Tests -
Table 73: Percentage Breakdown of Leading Players in Italian Market for Automated Tuberculosis Systems -
Table 74: Percentage Breakdown of Leading Players in Italian Market for Chlamydia Rapid Tests –
Table 75: Automated and Rapid Microbiological Tests Market by End- Use Segment in Italy: 2007-2015 (Sales in US$ Million)
Table 76: Percentage Breakdown of Automated and Rapid Microbiological Tests Market by End-Use Segment in Italy for the Years 2008 & 2009 2009
Table 77: Percentage Breakdown of Leading Players in Spanish Market for Automated Tuberculosis Systems –
Table 78: Automated and Rapid Microbiological Tests Market by End-Use Segment in Spain: 2007-2015 (Sales in US$ Million)
Table 79: Percentage Breakdown of Automated and Rapid Microbiological Tests Market by End-Use Segment in Spain for the Years 2008 & 2009 2009
Table 80: Automated and Rapid Microbiological Tests Market by End- Use Segment in Russia: 2007-2015 (Sales in US$ Million)
Table 81: Percentage Breakdown of Automated and Rapid Microbiological Tests Market by End-Use Segment in Russia for the Years 2008 & 2009 2009
Table 82: Percentage Breakdown of Leading Players in Streptococcal Infection Rapid Tests Market in Rest of Europe –
Table 83: Percentage Breakdown of Leading Players in Automated Identification and Susceptibility Systems Market in Rest of Europe –
Table 84: Automated and Rapid Microbiological Tests Market by End-Use Segment in Rest of Europe: 2007-2015 (Sales in US$ Million)
Table 85: Percentage Breakdown of Automated and Rapid Microbiological Tests Market by End-Use Segment in Rest of Europe for the Years 2008 & 2009 2009
Table 86: Automated and Rapid Microbiological Tests Market by End-Use Segment in Rest of World: 2007-2015 (Sales in US$ Million)
Table 87: Percentage Breakdown of Automated and Rapid Microbiological Tests Market by End-Use Segment in Rest of World for the Years 2008 & 2009 2009
Companies Profiled